Evidence map›Paper›PMID 40038652›Full record

ArticleJournal of nanobiotechnology2025

Cascade-recharged macrophage-biomimetic ruthenium-based nanobattery for enhanced photodynamic-induced immunotherapy.

Guoyu Xia, Zhongxiong Fan, Qingluo Wang, Jianmin Li, Yuxiang Zhang, Adila Aipire, Qiurong Su, Ying Li, Zhenqing Hou, Jinyao Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guoyu Xia *School of Pharmaceutical Sciences, Institute of Materia Medica, Xinjiang University, Urumqi, 830017, China.
Zhongxiong Fan *School of Pharmaceutical Sciences, Institute of Materia Medica, Xinjiang University, Urumqi, 830017, China. fanzhongxiong@xju.edu.cn.
Qingluo WangSchool of Pharmaceutical Sciences, Institute of Materia Medica, Xinjiang University, Urumqi, 830017, China.
Jianmin LiSchool of Pharmaceutical Sciences, Institute of Materia Medica, Xinjiang University, Urumqi, 830017, China.
Yuxiang ZhangXinjiang Medical University, Affiliated Hospital 6, Urumqi, 830002, China.
Adila AipireXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China.
Qiurong SuXiamen Key Laboratory of Traditional Chinese Bio-Engineering, Xiamen Medical College, Xiamen, 361023, China.
Ying LiXiamen Key Laboratory of Traditional Chinese Bio-Engineering, Xiamen Medical College, Xiamen, 361023, China. yinn.lee@163.com.
Zhenqing HouSchool of Pharmaceutical Sciences, Institute of Materia Medica, Xinjiang University, Urumqi, 830017, China. houzhenqing@xmu.edu.cn.
Jinyao LiXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China. ljyxju@xju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic-induced immunotherapy (PDI) is often hampered by low reactive oxygen species (ROS) yield, intra-tumor hypoxia, high glutathione (GSH) concentration, and immunosuppressive microenvironment. In view of this, a ruthenium (Ru)-based nanobattery (termed as IRD) with cascade-charged oxygen (O

Indexed as

Biomimetic MaterialsImmunotherapyMacrophagesPhotochemotherapyRutheniumAnimalsCell Line, TumorFemaleGlutathioneHumansIndocyanine GreenMiceMice, Inbred BALB CNeoplasmsPhotosensitizing AgentsRAW 264.7 CellsGlutathioneIndocyanine GreenPhotosensitizing AgentsReactive Oxygen SpeciesRutheniumHypoxiaMacrophage membranePhotodynamic immunotherapyRutheniumTumor therapy

Identifiers

PMID40038652
PMCPMC11881368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.